TGTX
TG Therapeutics, Inc.
$64.51−0.05 (−0.08%)Close Nov 13, 2026
Nov 5, 2012 – Nov 13, 2026, Dividends reinvested
- Final balance
- $305,735
- CAGR
- +27.63%
- Max drawdown
- −93.19%
- Sharpe ratio
- 0.70
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
TGTX's average annual return was 27.69% over the last 10 years, through Nov 13, 2026. $10,000 in TGTX on Nov 11, 2016 grew to $115,196 by Nov 13, 2026, with dividends reinvested.
Total
- 1M
- +18.72%
- 3M
- +34.56%
- 6M
- +51.25%
- YTD
- +116.40%
- 1Y
- +108.37%
Per year
- 3Y
- +84.63%
- 5Y
- +15.21%
- 10Y
- +27.69%
- Since 2012
- +27.63%
Annual returns
2012 from Nov 5 · 2026 through Nov 13
TGTX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 13 | +116.40% |
| 2025 | −0.96% |
| 2024 | +76.23% |
| 2023 | +44.38% |
| 2022 | −37.74% |
| 2021 | −63.48% |
| 2020 | +368.65% |
| 2019 | +170.73% |
| 2018 | −50.00% |
| 2017 | +76.34% |
| 2016 | −61.02% |
| 2015 | −24.68% |
| 2014 | +306.15% |
| 2013 | +7.14% |
| 2012 from Nov 5 | +72.51% |
Metrics
Since 2012| Volatility | 83.07% |
|---|---|
| Sortino ratio | 1.14 |
| Calmar ratio | 0.30 |
| Best year, 2020 | +368.65% |
| Worst year, 2021 | −63.48% |
| Positive years | 7 of 13 |
| Longest drawdown | 5.5 years |
Worst drawdowns
Since 2012| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −93.2% | Dec 2020 | Jun 2022 | Jun 2026 | 5.5 years |
| −81.7% | Mar 2015 | Dec 2018 | May 2020 | 5.1 years |
| −57.7% | Jun 2013 | Nov 2013 | Mar 2014 | 9 months |
| −40.6% | Mar 2014 | May 2014 | Jun 2014 | 3 months |
| −33.4% | Jul 2014 | Aug 2014 | Sep 2014 | 2 months |